Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionDanske Bank A/s
Latest Disclosed Ownership534,724 shares
Latest Disclosed Value $ 42,820,699
Danske Bank A/s reports 54.31% increase in ownership of EW / Edwards Lifesciences Corporation

On May 12, 2026 - Danske Bank A/s filed a 13F-HR form disclosing ownership of 534,724 shares of Edwards Lifesciences Corporation (MX:EW) valued at $42,820,699 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 346,523 shares of Edwards Lifesciences Corporation. This represents a change in shares of 54.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Edwards Lifesciences COM 28176E108 534,724 188,201 54.31 42,821 44.95 0.1032
2026-02-02 2025-12-31 13F Edwards Lifesciences COM 28176E108 346,523 32,200 10.24 29,541 20.85 0.0687
2025-11-19 2025-09-30 13F/A-1 Edwards Lifesciences COM 28176E108 314,323 10,010 3.29 24,445 2.71 0.0608
2025-12-18 2025-06-30 13F Edwards Lifesciences COM 28176E108 304,313 27,400 9.89 23,800 18.58 0.0591
2025-12-18 2025-03-31 13F Edwards Lifesciences COM 28176E108 276,913 -50,375 -15.39 20,071 -17.17 0.0613
2026-03-18 2024-12-31 13F Edwards Lifesciences COM 28176E108 327,288 45,075 15.97 24,229 30.10 0.0724
2026-03-18 2024-09-30 13F Edwards Lifesciences COM 28176E108 282,213 -135,834 -32.49 18,623 -51.77 0.0620
2026-03-18 2024-06-30 13F Edwards Lifesciences COM 28176E108 418,047 122,639 41.52 38,615 36.79 0.1425
2026-03-18 2024-03-31 13F Edwards Lifesciences COM 28176E108 295,408 295,408 28,229 0.0886
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.